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Chlamydia trachomatis Scc4 (formerly CT663) engages the transcription
machinery and the pathogenic type III secretion system (T3SS). Both machines are
required for Chlamydia infection. These requirements and the limited ability for genetic manipulation in Chlamydia have hampered dissection of Scc4’s contributions.
Here, by developing bacterial systems that permit the controlled expression and stable maintenance of Scc4, we assess Scc4’s effects on chlamydial growth phenotype,
secretion, and the patterns of T3SS gene expression. Expressing Scc4 in Escherichia
coli lacking a T3SS injectisome causes a growth defect. This deﬁciency is rescued by
overexpressing the ␤-subunit of RNA polymerase (RNAP) or by exploiting sigma 70
(70) (homologous to chlamydial 66) mutants that strengthen the interaction between 70 region 4 and the ␤-ﬂap, conﬁrming Scc4’s distinction as a module of
RNAP holoenzyme capable of modulating transcription. Yersinia pestis expressing
Scc4 sustains a functional T3SS, through which CopN secretion is boosted by cooption of Scc4 and Scc1. Finally, conditional expression of Scc4 in C. trachomatis results
in fast expansion of the Chlamydia-containing vacuole and accelerated chlamydial
development, coupled to selective up- or downregulation of gene expression from
different T3SS genes. This work reveals, for the ﬁrst time, the context-dependent action of Scc4 linking it to diverse protein networks in bacteria. It establishes that
Scc4, when overexpressed, exerts incredible effects on chlamydial development by
reinforcing control of the T3SS.
ABSTRACT

IMPORTANCE The T3SS is a key virulence factor required for C. trachomatis infec-

tion. The control of the T3SS has not been well studied in this obligate intracellular
pathogen. Here, we show that Scc4 plays a major role for precise control of the
pathogenic T3SS at the levels of gene expression and effector secretion through genetically separable protein networks, allowing a fast adaptive mode of C. trachomatis
development during infection in human epithelial cells.
KEYWORDS Chlamydia trachomatis, CopN, RNA polymerases, RpoB, Scc4,
developmental cycle, gene expression, sigma 66, type III secretion system,
transcription regulation

S

uccessful host cell infections require a fast and efﬁcient adaptation of the virulence
program by bacterial pathogens. Type III secretion systems (T3SSs) of the injectisome class are virulence determinants in numerous medically important bacteria,
including Yersinia, Chlamydia, Escherichia, Shigella, and Salmonella spp. (1–3). T3SSs
target bacterial effector proteins to the eukaryotic host’s cells for promoting pathogenesis. This infection mechanism holds particularly true for C. trachomatis. This
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obligate intracellular bacterium causes the most prevalent bacterial sexually transmitted diseases worldwide (4, 5). C. trachomatis relies on the T3SS to translocate more than
100 effectors into the host cell in order to invade, multiply within a membrane-bound
vacuole called an “inclusion,” exit from the host cell, and reinitiate new infections (6–8).
During the unique chlamydial developmental cycle, the organism transits between two
functionally and morphologically distinct forms, the infectious elementary body (EB)
and the dividing reticulate body (RB) (8, 9). The signal that triggers the interconversion
between EBs and RBs remains unclear. However, studies show that chlamydial development requires transcription of early-stage (EB-to-RB transition), midstage (RB replication), and late-stage (RB-to-EB transition) genes (10–12). Predictably, C. trachomatis
administrates its virulence gene expression program in a developmentally stagespeciﬁc manner.
Control of transcription, the ﬁrst step of gene expression, is crucial for correct gene
expression and orderly development. Bacterial transcription is determined by the RNA
polymerase (RNAP) holoenzyme, which consists of a core enzyme (␣2␤␤= subunits)
and a  factor (13). Transcription can be regulated by proteins that bind to a speciﬁc
subunit(s) of RNAP and modulate the activity of the enzyme. These regulatory proteins
include CarD from Mycobacterium tuberculosis (14), Rsd from Escherichia coli (15), DakA1
from Pseudomonas aeruginosa (16), and Scc4 from Chlamydia trachomatis (17). The
puzzle of transcription has been increasingly understood in C. trachomatis with methodological advances. C. trachomatis encodes conserved RNAP subunits (except ) and
three  factors (66, 54, and 28) to support its biphasic lifestyle (18, 19). Because the
 factors are not expressed in a typical cascade fashion, their levels alone cannot fully
explain the temporal gene expression in C. trachomatis. The majority of chlamydial
housekeeping genes, including all T3SS genes (20), are preceded by E. coli 70-like
promoter sequences. Their expression requires chlamydial 66 or E. coli 70 in vitro and
in E. coli (20–24). The availability of 66 is regulated by the Rsb phosphoregulatory
networks in C. trachomatis (25). Whereas some late genes are transcribed by 28 and/or
66, the target genes of 54 are unknown. Despite a central role in pathogenesis, the
mechanisms coordinating chlamydial morphological differentiation and virulence gene
expression remain largely unknown.
The premise of an intimate link between gene transcription and T3SS activation in
Chlamydia has emerged through the discovery of the bifunctional Scc4 protein (17, 26).
Scc4’s role as a transcriptional regulator was originally detected by its interaction with
the ﬂap domain of RNAP ␤-subunit (␤-ﬂap) and region 4 of 66 (70) in a bacterial
two-hybrid-based genetic screening (17). Later, in vitro transcription assays showed that
Scc4-bound 66 (70) RNAP holoenzyme had speciﬁc inhibitory effects on transcription
from ⫺35/⫺10 promoters but had few effects on extended ⫺10 promoters lacking a
⫺35 motif. Apart from its regulatory function, Scc4 forms a heterodimer with Scc1 to
chaperone CopN (26–28), a T3SS-exported effector and a gatekeeper, which is homologous to Yersinia YopN. By binding to its cognate chaperones, SycN/YscB and TyeA,
YopN negatively regulates the secretion of the Yersinia outer membrane proteins (Yops)
by preventing premature secretion of Yops until Yersinia receive an inductive signal
(e.g., low Ca2⫹) (29).
Despite these ﬁndings, the functional relevance of Scc4 in Chlamydia biology
remains elusive. We hypothesize that Scc4’s dual functions are switchable and contribute to precise coordination of T3SS activity and transcription events, stimulating the
chlamydial developmental cycle. This theory has not been experimentally tested yet. It
is difﬁcult to dissect Scc4’s exact contributions because both transcription and the T3SS
are required for Chlamydia infection. Recently, several methods for genetic manipulation of Chlamydia have developed (30–33). To test the functional importance of the
speciﬁc interplay between Scc4 and its associated proteins, here, we evaluate Scc4’s
effects on (i) bacterial growth phenotype, (ii) secretion of CopN via the T3SS, and (iii) the
dynamic expression of genes encoding the T3SS components in C. trachomatis. To
achieve these goals, we utilized genetic tools in E. coli and Yersinia, as well as the
recently developed genetic transformation of C. trachomatis. These ﬁndings reveal a
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FIG 1 E. coli expressing Scc4 displayed an arrested growth phenotype. (a) Growth curves showing
impaired E. coli growth in an IPTG-dependent manner. E. coli BL21(DE3) carrying pCDFScc4 was grown
in LB medium in the presence of increasing concentrations of IPTG (0, 10, and 100 M). Representative
data for growth plotted every 30 min by measuring the optical density at 600 nm (OD600) are shown.
Bacterial growth experiments were repeated three times. (b) IPTG-induced Scc4 expression. Stars indicate
the bands corresponding to the inducible Scc4 protein detected using 10% (wt/vol) sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) stained with Coomassie blue (upper panel) or by
immunoblotting with anti-Scc4 antibody (lower panel). (c) Plating assay analyzing bacterial viability. E.
coli strains carrying pCDFScc4 or pCDFlac (vector control) were cultivated in LB medium for an initial 1-h
incubation at 37°C, followed by adding IPTG at 100 M. After culturing for an additional 1 h, bacteria
were diluted and plated on LB agar plates. Colonies were counted after incubation for 16 h, and the data
are presented as the means ⫾ standard deviations (SD) from triplicate plates in a representative
experiment. The P value was obtained using unpaired t test. ns, no signiﬁcance.

context-dependent action of Scc4 involving interconnected protein networks and
suggest novel mechanisms of Scc4’s function to support dedicated control of the T3SS
during the C. trachomatis developmental cycle.
RESULTS
Scc4 overexpression causes a growth defect in E. coli by blocking the 70
region 4/␤-ﬂap interplay. We began our study by utilizing suitable vectors allowing
for expression of stable Scc4 in E. coli strains lacking the T3SS injectisome. E. coli
BL21(DE3) cells were transformed with pCDFScc4 expressing Scc4 tagged with His6 at
its N terminus. A single colony of bacteria was cultured in LB medium, and isopropyl␤-D-thiogalactopyranoside (IPTG) was added to induce protein expression. The growth
curve (Fig. 1a) shows that E. coli expressing Scc4 displayed a growth defect in an IPTG
dose-dependent manner, while the control (no IPTG addition) grew normally, indicating that the growth inhibition was Scc4 dependent. The IPTG-induced Scc4 expression
was conﬁrmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDSPAGE) and immunoblotting (Fig. 1b). Similar results were obtained in E. coli transformed
with pXDCM expressing tag-free Scc4 (17). When a high concentration of IPTG was
added (ⱖ100 M) into the early log-phase culture for 1 h, the amount of viable bacteria
identiﬁed by plating assays sharply decreased (Fig. 1c). Consistent with this, E. coli
exhibited a marked decrease in expression of 66-speciﬁc ompA promoter, 28-speciﬁc
hctB promoter (34), and E. coli 32-speciﬁc groE promoter (35), as identiﬁed by a
␤-galactosidase reporter assay (see Fig. S1 in the supplemental material). These results
August 2020 Volume 202 Issue 15 e00132-20
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FIG 2 Overexpression of RpoB rescues the growth defect of E. coli expressing Scc4. (a) Growth curve. The
indicated E. coli strains were grown in LB medium in the presence or absence of IPTG at a concentration
of 100 M, with OD600 measured at the indicated time points. Data are presented as mean ⫾ SD from
three replicates. (b) IPTG-induced expression of proteins in E. coli. The indicated E. coli strains were
cultured in LB medium containing increasing concentrations of IPTG (0, 20, 50, and 100 M) and
harvested at 2.5 h for preparation of lysates. Samples were separated by 10% SDS-PAGE and analyzed by
immunoblotting with anti-RpoB and anti-Scc4 antibodies, respectively, followed by visualization of
protein by probing with alkaline phosphatase-conjugated secondary antibodies. Note that a small
amount of Scc4 expression was observed without IPTG addition.

could be explained by transcription inhibition and bacterial death induced by Scc4
expression at a high level; thus, bacteria did not synthesize ␤-galactosidase.
Scc4 bound to the conserved 70 RNAP in E. coli (17). To determine whether toxicity
to E. coli is attributed to Scc4’s interaction with the 70 RNAP, E. coli carrying pXDCM
was transformed with pI545 encoding the full-length E. coli ␤-subunit of RNAP (RpoB)
or pET15b (vector control). Protein expression was induced by IPTG. Overexpressing
RpoB restored E. coli growth to the levels seen without Scc4 induction (Fig. 2a). A partial
rescue from Scc4’s toxicity occurred in E. coli expressing a fusion protein of 70 region
1 and 66 regions 2 to 4 (66R24) (36). The puriﬁed 66R24 protein showed transcription
activity in vitro (36). However, the growth was unchanged when full-length 66 was
expressed in E. coli. The reason for the inability of 66 to rescue is unclear, but we and
others noted inefﬁcient transcription using recombinant 66 and E. coli RNAP core
enzyme in vitro (22). The phenotypical rescue observed could be explained by (i)
excessive RpoB or 66R24 binding to Scc4 and (ii) changes in dedicated Scc4-70 RNAP
interactions induced by RpoB or 66R24, thus alleviating Scc4-meditaed growth inhibition. The possibility of poor expression or a low level of Scc4 was ruled out, as
steady-state levels of Scc4 were detected by immunoblotting (Fig. 2b).
If Scc4 binds the interfaces of 70 RNAP and interferes with transcription, the
creation of mutations that enhance the strength of the 70region 4/␤-ﬂap interaction
should be sufﬁcient to reduce toxicity. To test this possibility, we used the following
group of E. coli K-12 MG1655 strains (kindly provided by A. Hochschild, Harvard Medical
School): GS234 with wild-type chromosomal rpoD encoding 70, and its isogenic strains,
GS235 (rpoD A544I) and GS237 (rpoD A544I/D581G). These rpoD mutations have been
shown to strengthen the interactions between 70 region 4 and the ␤-ﬂap (37). The
strains were transformed with pCDFScc4 or pCDFlac (vector control). The levels of scc4
expression were ﬁne-tuned by IPTG concentrations (Fig. 3a). All resultant strains
exhibited comparable capacities for colony formation in the absence of IPTG, as
August 2020 Volume 202 Issue 15 e00132-20
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FIG 3 Exploiting rpoD mutations strengthening 70 region 4/␤-ﬂap interaction circumvents the impaired
growth of E. coli expressing Scc4. (a) IPTG-induced Scc4 expression. Scc4 expression was induced by
adding IPTG at increasing concentrations (0, 50, 100, and 200 M). Cellular lysates were prepared from
the indicated E. coli strains at 2.5 h and separated by 10% SDS polyacrylamide gels. The upper panel
shows a Coomassie blue-stained gel along with the protein markers (M). Lower panels show the results
of immunoblotting with anti-Scc4 antibody. (b) Colony formation assay. Equal volumes (5 l) of the serial
bacterial dilutions indicated at the bottom of the panel were spotted on a LB agar plate in the presence
of IPTG (at 0, 50, or 100 M) and incubated for 16 h at 37°C.

analyzed by colony formation (Fig. 3b). In contrast, upon the induction of Scc4 at similar
levels by adding IPTG at the concentration of 100 M, the bacterial dose responses to
Scc4 were notably different. Whereas E. coli GS234 expressing Scc4 grew poorly, GS237
was best suited to tolerate Scc4, and GS235 had an intermediate level of tolerance.
These data indicate that Scc4 acts as a module of 70 (66) RNAP that is capable of
dysregulating E. coli transcription, thereby causing growth arrest. The results of phenotypical rescue by overexpression of RpoB or 66R24 and by exploiting 70 mutants
that strengthen the 70 region 4/␤-ﬂap interplay suggest that the change in degree of
Scc4’s interactions with the 70 (66) RNAP holoenzyme represents a mechanism of
transcriptional regulation.
C. trachomatis Scc4 joining with Scc1 promotes CopN secretion through the
injectisome. Previously, Silva-Herzog et al. reported that Chlamydia pneumoniae Scc4
and Scc1 assisted in C. pneumoniae CopN secretion in Y. pestis (28). However, the
secretion chaperones are highly speciﬁc, and noted differences in biochemical properties exist between C. trachomatis CopN and C. pneumoniae CopN (38, 39). To
determine the speciﬁc role of Scc4 in the secretion of C. trachomatis CopN, a secretion
assay was initially performed using Y. pestis strain YP1283, which carries pCD1 encoding
all the Y. pestis T3SS components and effector Yops except YopE. No apparent increase
in CopN secretion was evident in Y. pestis YP1283 expressing CopN, Scc1, and/or Scc4
(see Fig. S2 in the supplemental material). However, the secretion of CopN was induced
under a low-Ca2⫹-level condition, indicating a functional T3SS. We suspected that the
level of CopN secretion was limited due to competition from the other highly expressed
endogenous effector Yops with their chaperones. Thus, the secretion assay was conducted with the Y. pestis strain YP769 that carried a mini-pCD1 with the minimal
genetics required for type III secretion and lacking genes encoding all six effector Yops
August 2020 Volume 202 Issue 15 e00132-20
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FIG 4 Scc4 and Scc1 enhance the secretion of CopN in Yersinia. (a) Immunoblotting analysis of CopN secretion in YP769. Y. pestis was
cultivated in HIB medium in the presence (⫹) or absence (⫺) of 2.5 mM Ca2⫹. After an initial 2 h of incubation at 26°C, IPTG (100 M)
was added. Bacterial cultures were then shifted to 37°C, and culturing was continued for 4 h prior to harvesting. Samples representing
culture supernatant and bacterial lysates were resolved on 12% polyacrylamide gels and analyzed by immunoblotting with anti-CopN
antibody, followed by visualization of protein by probing with alkaline phosphatase-conjugated secondary antibodies. (b) Analysis of
the ratio of secreted CopN levels (in supernatants) to the intracellular levels (lysates). Protein blots in panel a were measured using
ImageJ. The red line represents the background.

(40). YP769 cells were cotransformed with pCDFScc4 and pBAD24-CopN, which carried
copN, or with pBAD24-CopN-Scc1, which carried both C. trachomatis copN and scc1. In
these systems, the expression of scc4 was induced by adding IPTG, while the expression
of scc1 and/or copN was induced by adding arabinose. Coexpressing Scc4 and Scc1 in
YP769 clearly resulted in increased CopN secretion under secretion inducing conditions
(37°C; without Ca2⫹) (Fig. 4, lane 6). This increase did not occur in strains that lacked
Scc1, consistent with previous studies showing that Scc4 and Scc1 must form a
heterodimer to chaperone CopN and that Scc4 acted to bridge the Scc1 and CopN
interactions (26).
Given the successful CopN secretion in Yersinia expressing Scc4, it is unlikely that
Scc4 harshly compromised the synthesis and the assembly of the T3SS under our
experimental conditions. Unlike the impaired growth of E. coli, Scc4 expression does
not cause signiﬁcant growth restriction of Y. pestis (data not shown), indicating that
Scc4 does not appear to not strongly inhibit the Yersinia RNAP. In this context, the
effects observed are likely due to a role of the chaperone in possibly stabilizing its
substrate CopN.
It is possible that the Y. pestis chaperones are preventing Scc4 from interacting with
RNAP because of a tight binding of Scc4 with its chaperone pattern (26). Similarities
have been shown in the predicted structural properties between chlamydial Scc4 and
Y. pestis YscB and SycN (26). To test whether Scc4 directly interacts with Y. pestis
YscB/SycN, a bacterial two-hybrid assay was performed. This assay, using Y. pestis YscB
or SycN fused to the N-terminal domain of RNAP ␣ subunit (␣NTD) and Scc4 fused to
DNA binding domain CI, revealed that Scc4 bound to YscB and SycN (Fig. 5). Because
a heterodimeric chaperone is required for the secretion of YopN/CopN proteins (26–29),
the signiﬁcant secretion of CopN seen in the presence of Scc4 alone may be due to
minimal functional Scc4/SycN or Scc4/YscB in Y. pestis (Fig. 4 lane 4). Potential Scc4
interaction with YscB/SycN in Y. pestis may also explain the disparity in Scc4-mediated
growth inhibition between Y. pestis and avirulent E. coli strains. These T3SS proteins are
not present in E. coli, and thus it is unsurprising that bacteria display a growth defect
when Scc4 is overexpressed.
These results indicate that C. trachomatis Scc4 functioning with Scc1 helps promote
the secretion of CopN through the Yersinia injectisome in the presence of RNAP
subunits and some other T3SS components from Yersinia. This speciﬁc chaperoneassisted system should prove useful to further probe the determinants on the Scc4/
Scc1/CopN complex and their role in T3SS substrate recognition.
Inducible Scc4 protein is expressed from an E. coli-chlamydial shuttle plasmid
in C. trachomatis. We predict that Scc4 exerts distinct regulatory effects on chlamydial
August 2020 Volume 202 Issue 15 e00132-20
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FIG 5 Scc4 or Scc1 directly interacted with SycN and YscB in a bacterial two-hybrid assay. (a) Schematic
showing a transcription activation-based bacterial two-hybrid assay. In this system, protein-protein
interactions between the indicated hybrid proteins in a reporter E. coli strain, FW102 OL2-62, are
quantiﬁed by measuring ␤-galactosidase activities. (b) Immunoblot analysis of protein expression in
strain FW102 OL2-62 carrying pBR-yscB, pBR-sycN, or pBR␣ (vector control). Rabbit anti-YscB or anti-SycN
antibody was used to probe proteins as indicated. (c and d) Results of ␤-galactosidase activities
illustrating the protein-protein interactions. Note that SycN-Scc4 interactions (c) were stronger than
those of YscB-Scc4 (d). Protein expression in culture was induced by the addition of IPTG (50 M). Result
obtained from the negative control (CI) represents the background. Shown are the means ⫾ SD from
three biological replicates, each in technical triplicates.

biology. To determine the functional relevance of Scc4 in the unique chlamydial
developmental cycle, we sought to utilize recently developed chlamydial genetic
systems. Attempts to delete the chromosomal scc4 gene using the allelic exchange
replacement with ﬂuorescence protein mutagenesis (31) failed, perhaps because scc4 is
an essential gene in Chlamydia. We conducted an E. coli-C. trachomatis shuttle plasmid
transformation. Because Scc4 is highly toxic to E. coli, a tightly controlled strategy is
desirable. We chose pBOMBP3 to make an Scc4 expression vector (36) because it
contains (i) a tetracycline-inducible tetA promoter (PtetA) that drives expression of the
gene of interest in the presence of anhydrotetracycline hydrochloride (aTC) (41), (ii) a
␤-lactamase gene conferring ampicillin resistance that permits selection for the transformants, and (iii) a robust PompA-gfp reporter that allows for the easy visualization of
the growth behaviors of the transformants in live cells during the course of infection
(42, 43). We found that the native scc4 ribosome binding site (RBS) weakly functioned
to direct initiation of Scc4 synthesis in E. coli (see Fig. S3 in the supplemental material).
The DNA fragment containing the coding region and the scc4 RBS from C. trachomatis
L2/434/Bu was cloned into the pBOMBP3, allowing efﬁcient scc4 expression under the
control of PtetA in Chlamydia.
The resultant expression vector, pBOMBP3-Scc4 (Fig. 6a), was obtained and then
transformed into the plasmid-free C. trachomatis strain, L2/25667R. A single transformant isolate, designated L2/Scc4, carrying the cloned scc4 gene was conﬁrmed by PCR
(Fig. 6b) combined with Sanger sequencing. Ptet was responsive to aTC, and inducible
mCherry expression was visualized by immunoﬂuorescence microscopy (Fig. 6c). In the
presence of aTC at the concentrations of 5 and 50 ng/ml added immediately after
infection (0 hours postinfection [hpi]), inducible Scc4 protein was detected in L2/Scc4infected L929 cells or HeLa cells at 24 hpi using immunoblotting (Fig. 6d and e). No
inducible Scc4 was detected in the cells infected with the pBOMBP3-carrying control
August 2020 Volume 202 Issue 15 e00132-20
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FIG 6 Ectopic expression of Scc4 in C. trachomatis from a shuttle plasmid. (a) Map of pBOMBP3-Scc4. (b) Veriﬁcation
of the stable presence of a plasmid-encoded scc4 gene in C. trachomatis strain L2/Scc4 but not in L2/vector
(control) using PCR with primers scc4F and mCherryR1 (see Table S2 in the supplemental material). (c) Microscopic
analysis of anhydrotetracycline hydrochloride (aTC)-induced mCherry expression in C. trachomatis. Images were
taken at 24 hpi. Bar, 20 m. (d) Immunoblot analysis of aTC-induced Scc4 expression in C. trachomatis-infected
HeLa cells. Cells were cultured in medium containing increasing amounts of aTC (0, 5, and 50 ng/ml) at 0 hpi,
harvested at 24 hpi, and lysed in 10 mM Tris-HCl (pH 7.6) and 8 M urea buffer. Samples were isolated on SDS-PAGE,
followed by immunoblotting with antibodies speciﬁc to Scc4 or RpoB (as a protein loading control). (e) Quantitative
analysis of protein blot from panel d.

strain, L2/vector. When the same multiplicity of infection (MOI) was used, consistent
levels of infection with L2/Scc4 and L2/vector were obtained, suggesting no apparent
adverse impact of Scc4 on infection efﬁciency. An aTC dose of 10 ng/ml was chosen for
subsequent experiments.
Ectopic expression of Scc4 induces changes in C. trachomatis development.
Productive C. trachomatis infection is signiﬁed by expansion of the chlamydial inclusions in parallel, the EB-to-RB differentiation at the early stage, RB replication at the
midstage, and RB-to-EB differentiation at the late stage (8). To assess the effects that
Scc4 had on Chlamydia development, we employed HeLa cells, rather than L929 cells,
because of their cervical origin and their wide use in C. trachomatis research. HeLa cells
were equally infected with L2/Scc4 or L2/vector and cultured in medium containing or
lacking aTC added immediately after infection (0 hpi) for an early induction of Scc4
expression. The morphology of chlamydial inclusions was monitored using microscopy
at 16 hpi and 24 hpi, respectively. Infection of HeLa cells with L2/Scc4 or L2/vector
resulted in morphologically normal inclusions, but there were differences in the inclusion sizes in the absence or presence of aTC. Figure 7a shows that histograms of the
areas of L2/vector inclusions measured at 16 hpi are biased toward the left in the
presence of aTC, indicating a small number of large inclusions compared to the control
without aTC addition (Fig. 7b). In contrast, in the presence of aTC, there were more
large inclusions in L2/Scc4-infected cells (Fig. 7c) than in those without aTC (Fig. 7d). As
the chlamydial inclusions grew with time, differences in inclusion sizes between
L2/Scc4 and L2/vector were not obvious when analyzed at 24 hpi and later.
To address whether the expansion of the inclusions correlated with RB progeny
production, we enumerated RBs at 16 hpi when few EBs were being produced. Fifty
inclusions per condition were analyzed. Although normal RBs were produced with C.
trachomatis L2/Scc4 or L2/vector, the number of RBs in L2/Scc4 was more numerous
than that in L2/vector when Scc4 was induced (Fig. 8). We next assessed the chlamydial
genome copies by performing quantitative PCR with primers speciﬁc to tufA encoding
the translation elongation factor EF-Tu (21). Like other cells, C. trachomatis duplicates its
genomes prior to dividing. Consistent with the results of RB counts, the genome copies
were signiﬁcantly higher in L2/Scc4 than L2/vector. These data suggest the positive
impact of early Scc4 induction on RB replication.
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FIG 7 Histogram of C. trachomatis inclusion areas in HeLa cells in the absence or presence of aTC. (a and b) L2/vector; (c and d) L2/Scc4. HeLa cells were infected
with C. trachomatis with the same multiplicity of infection (MOI) (1:0.5), cultured in the aTC-free (⫺aTC) or aTC-containing (⫹aTC) medium (at a concentration
of 10 ng/ml) starting from 0 hpi, and imaged at 16 hpi. The individual inclusions were analyzed using ImageJ software. The numbers of inclusions analyzed per
condition are indicated. The histogram was made with R software. In each case, the frequency of an inclusion is equal to the number of observations falling
in that category.

We next compared the production of EB progeny by monitoring the appearance of
EBs in the presence or absence of aTC. Equally infected HeLa cells were harvested at
different time points after infection to enumerate EB progeny using the inclusionforming unit (IFU) assay. As expected, IFUs were extremely few at 12 hpi and signiﬁcantly increased at 16 and 26 hpi in all samples (Fig. 9 and Fig. S3). In the presence of
aTC, the yield of EBs increased by ⬃9.7-fold in L2/Scc4 from 16 to 24 hpi. The increase
is signiﬁcantly compared to that (6.2-fold) in L2/vector (P ⬍ 0.05). In contrast, fewer EBs
were produced in L2/Scc4 from 16 to 24 hpi (5.1-fold increase) than in L2/vector
(11.8-fold increase) in the absence of aTC (P ⬍ 0.05). The difference was less appreciable
between C. trachomatis L2/Scc4 and L2/vector when measured at 32 hpi, regardless the
use of aTC (Fig. S3). To validate the IFU data, the levels of EB-speciﬁc OmcB expression
were determined using an immunoﬂuorescence assay (IFA). In the presence of aTC,
OmcB-positive chlamydial organisms were readily detected in L2/Scc4 culture at 24 hpi,
and fewer were seen in L2/vector culture (Fig. 9c).
The serial quantitative analyses of inclusion size, RB progeny, and EB progeny
provide direct evidence that C. trachomatis adapts an accelerated mode of growth with
early Scc4 induction. The appearance of small inclusion sizes and the small amounts of
RBs and RBs in L2/vector-infected cells in the presence of aTC might be the reﬂection
of a bacterial response to a low dose of aTC or ﬁtness cost of the transformed plasmid
expressing exogenous proteins, such as mCherry. Conversely, the better growth of
L2/Scc4 in the presence of aTC could be explained by the induction of Scc4 that
August 2020 Volume 202 Issue 15 e00132-20

jb.asm.org 9

Gao et al.

Journal of Bacteriology

FIG 8 Effect of Scc4 on RB replication. (a) Numeration of RBs. Live cell images were taken at 16 hpi. The number
of each single inclusion was counted manually and presented as the mean ⫾ SD. In total, 50 different inclusions
per condition were analyzed. The P value was obtained by one-way analysis of variance (ANOVA) with a Bonferroni
posttest. (b) Representative live cell imaging of RBs within a chlamydial inclusion. Bar, 5 m. (c) Quantiﬁcation of
chlamydial genome copies by real-time qPCR. The primers designed to amplify tufA were used for PCR with DNA
prepared from C. trachomatis-infected HeLa cells harvested at 16 hpi. The serial dilution of genomic DNA from
puriﬁed EBs was used to generate a standard curve, with which the corresponding genome copies of the testing
samples were calculated and presented as means ⫾ SD. gDNA, genome DNA. Data from two individual experiments are shown; each experiment was performed in triplicate.

facilitates the chlamydial organisms to overcome the barriers of ﬁtness cost. The
enhancement of chlamydial growth observed at 16 to 24 hpi is relevant to the induced
exogenous Scc4 because endogenous Scc4 content does not reach a high level until
the late stage (17, 26). However, the interpretation of Scc4’s effect at the late stage

FIG 9 Effect of Scc4 on EB production. (a and b) Monitoring the appearance of EBs in the presence or absence of aTC.
HeLa cells were infected with L2/Scc4 (a) or L2/vector (b). EB progeny were assessed by IFU assays with samples collected
at different time points as indicated (for a one-step growth curve, see Fig. S4 in the supplemental material). The data are
presented as means ⫾ SD. Numbers above the bars give the fold increase from 16 to 24 hpi. (c and d) Analysis of
EB-speciﬁc OmcB expression using IFA. C. trachomatis-infected cells were cultured in the medium containing aTC, ﬁxed
at 24 hpi, and subjected to IFA with anti-OmcB antibody, followed by staining with Alexa Fluor 405-conjugated
anti-rabbit IgG. (c) Shown are chlamydial inclusions containing green ﬂuorescent protein (GFP)-positive C. trachomatis
(green) and OmcB-labeled EBs (purple pseudocolor). Bar, 10 m. (d) Ratio of mean ﬂuorescence intensity (MFI) of
OmcB-labeled EBs to GFP-positive organisms per inclusion. Error bars represent means ⫾ SD obtained from 30 inclusions
per condition. The P value was obtained using an unpaired t test.
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FIG 10 Altered transcription patterns of select T3SS genes induced by Scc4. (a) Map of T3SS genes/operons
analyzed. The expression of genes marked in red was assessed by RT-qPCR. (b) The heat map shows relative
transcript abundance of genes in L2/vector or L2/Scc4 culture at 0, 6, 24, and 30 hpi as indicated by RT-qPCR. (c)
Comparison of relative transcript abundance of sctU in L2/vector and L2/Scc4. Data were normalized to transcript
of tufA and calibrated against the 0-hpi control (set to 1.0). Each value shows the mean ⫾ SD of three technical
replicates of a representative experiment. At least three independent experiments were performed. P values were
obtained using one-way ANOVA. *, P ⬍ 0.05; ***, P ⬍ 0.001; ****, P ⬍ 0.0001.

might be more complex due to the increase in endogenous Scc4 and/or its associated
proteins and the natural asynchrony of C. trachomatis growth.
Expression of T3SS genes is altered by induction of Scc4 expression in C.
trachomatis. Our data thus far have suggested that Scc4 expression accelerates the
developmental cycle of C. trachomatis. Most genes encoding the T3SS components are
tightly regulated due to their role in pathogenesis (1–3). To test whether Scc4 affects
virulence gene expression in the intracellular milieu, we assessed transcript levels of
genes encoding chlamydial T3SS components during the course of infection using
real-time reverse transcription-quantitative PCR (RT-qPCR). HeLa cells infected with C.
trachomatis L2/Scc4 or L2/vector were cultured in medium containing aTC (at 10 ng/ml)
and harvested at 0, 6, 24, and 30 hpi for RNA extraction. Unlike many other bacteria that
possess T3SS gene clusters in a pathogenicity island on the chromosomes or plasmids,
Chlamydia encodes T3SS genes scattered throughout the chromosome in different
operons. Therefore, the representative T3SS genes encoding functionally diverse T3SS
components, including the secretion chaperones (scc1 and slc1), effectors (incD and
CopN), and T3SS inner membrane protein (sctU), were analyzed (Fig. 10a). Scc1 acts as
a class 1a chaperone to interact with CopN together with Scc4. Slc1 serves as a class 1b
chaperone, which, like EPEC CesT, binds multiple effectors, including Tarp (44) and TepP
(45). Whereas incD codes for a Chlamydia-speciﬁc Inc protein crucial for recruitment of
the lipid transfer protein CERT (46), sctU codes for a T3SS inner membrane protein that
regulates the export apparatus (1, 2). The reference early gene, euo (47), and late gene,
omcB (48), were also tested. The validated chlamydial housekeeping gene tufA was
used as an internal control for quantitation of mRNA levels.
There was almost full concordance in euo and incD transcript levels in the C.
trachomatis strains L2/Scc4 and L2/vector (Fig. 10b), consistent with their nature of
early expression (49). In contrast, we found striking differences in the transcription
proﬁles of scc1, slc1, copN, and sctU between L2/Scc4 and L2/vector over the same time
course. Such discrepancies were more apparent at 30 hpi. Whereas the transcript levels
were signiﬁcantly low for sctU and high for scc1, copN and slc1 in L2/Scc4 and L2/vector
exhibited different patterns (Fig. 10c). The increased levels of scc1, copN, and slc1 in
L2/Scc4 are comparable to that of omcB in the same culture, in good agreement with
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the ﬁndings showing accelerated EB accumulation in L2/Scc4 using both IFU assays and
IFA (Fig. 9). However, the low sctU levels opposing the high levels of scc1 and copN in
L2/Scc4 are not easily explained, as a previous study indicated that sctU is located in the
same operon as copN and scc1 (20). The low sctU level is not due to gene mutation, as
DNA sequencing data prove the integrity of this region in L2/Scc4. The observations
showing that the extent and the pattern of transcript expression are unique to the
Scc4-expressing strain, L2/Scc4, support the hypothesis that Scc4 induces a speciﬁc
gene expression signature during infection.
DISCUSSION
Although the developmental cycle of C. trachomatis has been widely studied, there
is scarce information regarding how C. trachomatis executes its virulence program
during infection. In the studies presented, we obtained several lines of evidence in
support of the notion that Scc4 plays a major role for precise control of pathogenic
T3SS expression through genetically separable protein networks involving 66RNAP
holoenzyme and the T3SS in this pathogen. Importantly, our work supports a functional
role for Scc4 in C. trachomatis virulence gene expression in its unique intracellular niche.
These data indicate a complexity of T3SS control that would not be apparent without
identifying the mode of action of Scc4 dynamically interacting with its numerous
protein partners.
The current study uses several heterologous systems for the inducible expression of
target proteins at a given time, enabling the rigorous investigation of Scc4’s contextdependent actions in bacteria. An interesting ﬁnding was that Scc4 expression had a
dramatic inhibitory effect on the growth of E. coli. We characterized the mechanisms of
growth suppression of Scc4 for E. coli and established that Scc4 acted as an active
module of the 70 (66) RNAP holoenzyme and modulated bacterial transcription (Fig.
1 and 3). The ability of C. trachomatis Scc4, by cooperation with Scc1, to promote the
secretion of CopN via the T3SS injectisome was observed in an engineered Y. pestis
strain (Fig. 4 and 5), consistent with results of previous work with C. pneumoniae CopN
(28). The observations in the CopN secretion, growth phenotype, and bacterial twohybrid assays suggest that interconnected protein networks inﬂuence Scc4’s action.
These data suggest that well-designed heterologous systems are useful to study how
Scc4 functions with the conserved RNAP or T3SS components through dedicated
protein-protein interactions in bacteria.
In an important extension to chlamydial genetic manipulation using plasmid transformation, we showed that the early induction of Scc4 clearly accelerated C. trachomatis
development (Fig. 6 and 9). Our RT-qPCR data demonstrated the ability of Scc4 to
selectively up- or downregulate T3SS gene expression during C. trachomatis infection
(Fig. 10). A previous in vitro study (17) only suggested Scc4’s inhibitory effect on
transcription from chlamydial rRNA P1 (24) and tuf P1 (21), both of which have
architectures similar to those of E. coli 70-directed promoters. This highlights the need
to investigate the widespread inﬂuence of Scc4 on C. trachomatis promoters that may
be diverse in structure in their native state during Chlamydia infection. It is noteworthy
that Scc4 shares an intrinsic feature with T4 AsiA (50, 51), with both being a module of
the RNAP holoenzyme and modulating this enzyme’s activity without interacting with
DNA. AsiA is not a typical anti- factor, because it acts to inhibit transcription from the
70-recognized ⫺35/⫺10 promoters and also serves as a coactivator for T4 middle
promoters that hold the canonical 70 ⫺10 consensus sequence but retains a MotAbox site centered at ⫺30 rather than the 70 ⫺35 sequence (52). There may be
similarities with the function of Scc4, for example, as either a repressor or coactivator
in the presence of certain activators and dependent on the intrinsic properties of
promoters.
It is interesting that the transcript level of sctU is signiﬁcantly lower than that of
other genes in the sctU-lcrD-copN-scc1-malQ gene cluster in L2/Scc4. In principle, the
low levels of sctU suggest decreased synthesis or increased mRNA decay. Given sctU’s
position at the start of the gene cluster, these results raise two different possibilities.
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The ﬁrst possibility is the existence of two divergent mRNAs derived from different
promoters, one containing the coding regions for the copN-scc1-malQ gene cluster and
the other containing only the region for sctU-lcrD. In supporting this idea, Albrecht et
al. (53) identiﬁed separate transcription start sites at the 5= ends of copN and sctU,
respectively, using deep RNA sequencing. The second possibility is that Scc4 takes part
in the regulation of sctU mRNA decay. Ferreira et al. (54) have stated that the interplay
between transcript production and degradation is driven by complex transcriptional
networks in Chlamydia. It remains to be determined whether Scc4 directly affects sctU
transcription. Alternatively, downregulation of sctU expression results from an indirect
mechanism, for example, an RNA binding protein or noncoding RNA (ncRNA) whose
expression and functions are regulated by Scc4. Notably, all C. trachomatis ncRNAs
identiﬁed were expressed from 66 promoters (55), and an ncRNA, ctrR3, was proposed
to regulate sctU and other genes (53).
It has been documented that the activity of the T3SS is carefully regulated at
multiple steps (3), which include (i) expression of the T3SS genes, (ii) assembly of
protein components into a structural apparatus, (iii) substrate recognition and selection, and (iv) spatiotemporal effector secretion. While transcription modulation by Scc4
per se certainly affects the T3SS synthesis, evidence for Scc4’s role in facilitating CopN
secretion through the T3SS was also obtained here (Fig. 4), consistent with previous
work with C. pneumoniae CopN (28). Thus, Scc4 may inﬂuence control of the T3SS at the
levels of gene expression and effector secretion. Tight control of the T3SS leads to
efﬁcient T3SS function, allowing correct and suitable levels of effectors being translocated into the host cell. The inducible Scc4 system alone cannot easily determine Scc4’s
inﬂuence on secretion activity in diverse chlamydial developmental forms due to the
presence of endogenous Scc4, asynchronous Chlamydia development and the inherent
difﬁculty in accurate measurement of the spatiotemporal secretion of T3SS effectors in
C. trachomatis-infected cells. Nevertheless, the view for the common function of the
YopN gatekeeper family is that upon completion of the apparatus assembly, the
gatekeepers are secreted or alter their interaction with the T3S apparatus, thereby
controlling the substrate speciﬁcity of the T3SS apparatus (29). These ﬁndings support
the appealing model proposed (1, 26, 28) that association or dissociation of CopN with
the Scc4-Scc1 complex might affect T3SS substrate recognition and, in turn, the
effective secretion of effectors. Inputs of dynamic Chlamydia-host interactions are likely
critical for the adaptable control of the activity of the T3SS.
All of the evidence presented supports a vital role for Scc4 and its associated
proteins in controlling the T3SS in C. trachomatis. How does Scc4 exert its dual function
to contribute to the chlamydial developmental cycle? Our prevailing model suggests
that Scc4 undergoes a developmental stage-speciﬁc functional and structural switch,
leading to cooperativity of key events of transcription and the T3SS during the
chlamydial developmental cycle. Whereas an EB is fully equipped for the T3SS apparatus, its contact with the host cell induces secretion of CopN, followed by other
effectors to promote EB entry and transition to RB. Scc4 is freed from the Scc4-Scc1
complex and/or is newly synthesized in RBs, where Scc4 performs its regulatory duties
by binding and remodeling 66RNAP. When RBs differentiate to EBs, there are the low
levels of 66RNAP due to modulation of 66 by Rsb kinases/phosphatases and the high
abundance of 28 accumulation. Scc4 rather binds to the accumulated Scc1 to form a
heterodimeric chaperone that stabilizes CopN as a gatekeeper in the T3SS, blocking
premature effector secretion from EBs. Because the afﬁnity of the T3SS chaperone
complex is very high, the presence of Scc1 may provide negative feedback for Scc4’s
interaction with RNAP in EBs. In support of this switch model, we have recently
uncovered a unique allosteric mechanism of Scc4 toward RNAP over T3SS components
using mutation, biochemical, and nuclear magnetic resonance approaches (our unpublished data). It is important to take into account the developmental stage-speciﬁc
function of Scc4. These mechanisms may not necessarily be mutually exclusive during
chlamydial infection, because diverse chlamydial forms coexist at the late developmenAugust 2020 Volume 202 Issue 15 e00132-20
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tal stage in particular. In this case, Scc4’s dual function, in combination, may mediate
adaptation of the chlamydial organisms as heterogeneous multiple cell population.
In conclusions, our data indicate that Scc4 plays a multitude of roles in the
chlamydial developmental cycle. Scc4 participates in quality control of gene expression
by binding and modulating RNAP activity, allowing for the expression of the correct
class of genes at the correct time and order. On the other hand, Scc4 brings an
additional layer of plasticity to enable spatiotemporal control of ordered T3SS secretion
and other related processes. Further work using RNA sequencing combining with other
methods is warranted to understand the nature of Scc4’s effects on genome-wide
chlamydial gene expression and how this leads to the developmental stage-dependent
control of T3SS activity during infection. In addition, it is merited to use site-directed
mutagenesis in the chlamydial Scc4 expression system to differentiate Scc4’s transcriptional effects from chaperone function in future. The practical aspects of the strategy
described and the extended methodologies for vector and strain improvement to
obtain the desired yield of target protein would be broadly applicable to address other
mechanistic questions and accomplish molecular details useful for a therapeutic strategy against Chlamydia infection.
MATERIALS AND METHODS
Molecular cloning. Plasmids used in this study are listed in Table S1 in the supplemental material.
The expression vectors pCDFScc4, pXDCM, pLN-66R24, and pIA545 were reported previously (17, 26, 36).
These plasmids encode Scc4 with an N-terminal His6 tag, tag-free Scc4, tag-free 70 (residues 1 to 327)
fused to C. trachomatis 66 regions 2 to 4 (residues 315 to 571), and E. coli RpoB with an N-terminal His6
tag, respectively. To construct expression plasmids pBAD24-CopN-Scc1 or pBAD24-Scc1, the target genes
were generated as PCR products using C. trachomatis serovar D genomic DNA as a template as a
restriction enzyme-digested fragment and then cloned in pBAD24 (56). Both copN and scc1 or scc1 alone
are controlled by an arabinose-inducible Para promoter. pQF50k-groE carrying the lacZ gene driven by
the E. coli 32-dependent groE promoter (35) was kindly provide by Petier deHaseth (Case Western
Reserve University). The plasmid pRVhctB containing the lacZ gene driven by the chlamydial 28dependent hctB promoter was reported previously (34). To construct the reporter plasmid pRVompA, the
PCR fragment containing ompA P2 and P3 was inserted into the EcoRI and SalI sites of pRVhctB. To
construct plasmids encoding the fusion proteins of the E. coli N-terminal domain of the RNAP ␣ subunit
(␣-NTD; residues 1 to 236) and Yersinia YscB or SycN, the gene fragments were ampliﬁed by PCR, digested
with NotI/SpeI, and cloned into the NotI/SpeI sites of pRBR (17). Plasmids pRAC, pACcI-CT663 (here
renamed pACScc4), and pACScc1 have been described previously (17, 26). They express DNA binding
protein CI, CI fused to Scc4, and CI fused to Scc1, respectively. The identities of the ﬁnal cloned DNA
inserts for all plasmids were conﬁrmed by restriction mapping and Sanger sequencing.
E. coli DH5␣ and its derivative 5-␣ F=Iq cells (no. C2992; New England Biolabs [NEB]) were used as host
cells for molecular cloning. A methylation-deﬁcient E. coli strain (ER2925; NEB) was used to prepare the
plasmids for C. trachomatis transformation. The E. coli cells were grown in Luria-Bertani (LB) medium or
on agar plates. When appropriate, antibiotics were used at the following concentrations: kanamycin,
25 g/ml; carbenicillin, 50 g/ml; chloramphenicol, 30 g/ml; and spectinomycin, 100 g/ml.
Cell culture, C. trachomatis infection, and IFU assay. Human cervix adenocarcinoma epithelial
HeLa 229 cells (ATCC CCL-2.1) or mouse ﬁbril blast cell L929 (ATCC CCL-1) were cultured in RPMI 1640
(Gibco) supplemented with 10% fetal bovine serum (FBS; Sigma) and L-glutamine (2 mM) (RPMI 1640-10)
at 37°C in a humidiﬁed incubator with 5% CO2. For infection, C. trachomatis EBs were added to the cell
monolayers (MOI ⫽ 0.5), followed by centrifugation at 255 ⫻ g for 45 min at 37°C. Infected cells were
cultured in medium at 37°C for various times as indicated in Results. EB progeny were evaluated by
endpoint IFU assays. Brieﬂy, serial dilutions of cellular lysates from the harvested cultures were subcultured in HeLa 229 cells. The cells were processed at 42 hpi for indirect immunoﬂuorescence assay (IFA)
as described below using antibody against the major outer membrane protein (MOMP). EB amounts
were determined by enumeration of the inclusion numbers in triplicate wells using ﬂuorescence
microscopy. The total EB numbers are presented as the number of IFUs per ml.
Transformation of C. trachomatis. C. trachomatis was transformed with the shuttle plasmids
according to a method described previously (36, 57). Brieﬂy, plasmid-free C. trachomatis L2/25667R EBs
(1 ⫻ 107) were mixed with 7 g of plasmid DNA in 100 l of CaCl2 buffer (5 mM Tris-HCl [pH 7.4] and
100 mM CaCl2) and incubated at room temperature for 30 min. Freshly trypsinized L929 cells (6 ⫻ 106)
resuspended in 200 l CaCl2 buffer were added to the plasmid/EB mixture and incubated at 37°C for an
additional 20 min. Aliquots of this mixture were then added to a 6-well plate with 1.0 ml of prewarmed
medium in each well. After culturing in Dulbecco’s modiﬁed Eagle’s medium (DMEM) containing 10% FBS
without antibiotics at 37°C for 24 h, cells were incubated in the presence of ampicillin (5 g/ml) and
cycloheximide (2 g/ml) for an additional 24 h. The infected cells were harvested and lysed by vortexing
with glass beads and passed onto the fresh monolayer cells. The cloned, transformed C. trachomatis
strains were used to infect HeLa 229 cells. EBs were isolated by density gradient puriﬁcation as described
previously (58) and resuspended in sucrose-phosphate-glutamic acid (SPG) buffer. The aliquots were
stored at ⫺80°C until use.
August 2020 Volume 202 Issue 15 e00132-20

jb.asm.org 14

Scc4 Controls the Type III Secretion System

Journal of Bacteriology

Antibodies. The primary antibodies used in this study were (i) polyclonal mouse antibody against
Scc4 (17), (ii) monoclonal antibody 8RB13 (recognized E. coli ␤ and C. trachomatis ␤) purchased from
NeoClone, (iii) polyclonal anti-CopN (kindly provided by Ken Fields, University of Kentucky), (iv) polyclonal anti-OmcB (kindly provided by Thomas P. Hatch, University of Tennessee), (v) mouse monoclonal
antibody against LGV L2 MOMP (kindly provided by You-xun Zhang, Boston University), and (vi) rabbit
anti-YscB and anti-SycN (29). The secondary antibodies, goat anti-rabbit IgG (H⫹L)–Alexa Fluor 405, goat
anti-mouse IgG (H⫹L)–Alexa Fluor 488, goat anti-mouse IgG (H⫹L)–Alexa Fluor 567, and goat anti-mouse
or anti-rabbit IgG–alkaline phosphatase (Invitrogen), were purchased from Invitrogen.
Microscopic analysis and IFA assay. HeLa cell monolayers grown in a black 96-well culture plate
were infected with C. trachomatis at an MOI of 0.5. The cultures were photographed directly with an
inverted ﬂuorescence microscope (Axio Observer D1; Zeiss). For IFA experiments, C. trachomatis-infected
cells were ﬁxed by 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and immunostained
with the antibody to OmcB overnight at 4°C. After washing extensively, the cells were incubated with
Alexa Fluor 405-conjugated secondary antibody for 45 min at 37°C. Images were obtained with a
ﬂuorescence microscope (Zeiss) and processed using AxioVision software.
E. coli growth curve, plate assay, and colony formation assay. A single bacterial colony was
inoculated into LB medium containing the proper antibiotics and cultured at 37°C overnight. The
overnight culture was diluted in fresh medium at a ratio of 1:100 and cultured in LB medium with or
without IPTG and shaken at 37°C. Two complement methods were used to evaluate the growth of E. coli
(Fig. 1). In the ﬁrst, culture samples were taken to measure the optical density at 600 nm (OD600) every
30 min. The absorbance values were plotted against the growth time. In the second, growth was assessed
by plating serially diluted cultures on LB agar in the absence of IPTG. CFU were enumerated after
incubation at 37°C for 16 to 24 h. For the colony formation assay (Fig. 3), the overnight cultures were
diluted in fresh medium at a ratio of 1:100 and cultured in LB medium without IPTG at 37°C for 2 h. The
cultures (200 l) were collected for the series of 1/10 dilutions. An equal volume (5 l) of each dilution
was spotted on a LB agar plate containing IPTG (at concentrations of 0, 50, or 100 M) and incubated for
16 h at 37°C.
Yersinia growth and secretion assay. Y. pestis strain YP1283 carries a pCD1 plasmid with a
functional T3SS but the yopE gene is deleted (and a dhfr gene is inserted). YP769 carries a mini-pCD1
plasmid (pCD1-Δ1234) that is deleted for all six effector Yops and their chaperones (40). This strain also
lacks the pPCP1 plasmid encoding Pla. Y. pestis cultures were routinely grown in heart infusion broth
(HIB) or on tryptose blood agar base plates (BD Difco) at 27°C. For secretion assays, Y. pestis strains were
grown in TMH medium in the presence or absence of 2.5 mM CaCl2 as described previously.
Determination of promoter activity in E. coli using ␤-galactosidase assay. Promoter activity was
determined by measurement of the ␤-galactosidase reporter genes in E. coli. Cells harboring the
appropriate plasmid(s) were grown overnight in LB medium. Cultures were diluted 1:100 in fresh LB
medium to an OD600 of 0.3, and the expression of protein was induced by adding IPTG to the culture.
To quantify the ␤-galactosidase expressed in E. coli, 200-l portions of cultured cells were collected at
different times and subjected to a plate ␤-galactosidase assay as described previously (59).
Bacterial two-hybrid assay determination of protein-protein interaction. The competent E. coli
reporter strain FW102 OL2-62 was transformed with two compatible plasmids. One expressed the ␣
fusion proteins (e.g., ␣-YscB or ␣-SycN). The other expressed the CI fusion proteins (e.g., CI-Scc1 or
CI-Scc4). Each single colony of transformant was inoculated in LB medium containing ampicillin and
chloramphenicol overnight. The overnight culture was then diluted at 1:50 in fresh LB medium and
continued culturing in the presence of IPTG (50 M) to induced protein expression. Cultures grown to log
phase were harvested and subjected to a ␤-galactosidase plate assay as described above.
Real-time quantitative PCR (qPCR) and reverse transcription quantitative PCR (RT-qPCR). HeLa
cells infected with C. trachomatis were harvested at the times postinfection as indicated in Results. DNA
and RNA were isolated using the Quick DNA/RNA miniprep kit (Zymo). For qPCR, the tufA gene was
ampliﬁed using the VeriQuest Fast SYBR green qPCR mastermix (USB) with primers tufF and tufR (see
Table S2 in the supplemental material) in 10 l of reaction mixture on a real-time PCR system (Bio-Rad).
Each sample was run in triplicate in a 96-well plate. A negative control containing no C. trachomatis DNA
was included in each reaction setup. The PCR cycle conditions were as follows: 50°C for 2 min, 95°C for
5 min, 95°C for 3 s, and 60°C for 30 s. A standard curve was taken from puriﬁed C. trachomatis genomic
DNA with the serial dilutions.
For RT-qPCR, a total of 2 g of RNA was reverse transcribed into cDNA using the high-capacity cDNA
reverse transcriptase kit (Thermo Fisher). Dilution of cDNA was used for ampliﬁcation of the genes of
interest in a total volume of 20 l using the PowerUp SYBR green mastermix (Thermo Fisher) on a
real-time PCR system (Bio-Rad). The primers used are listed in Table S2. Triplicate samples were run for
each target transcript. The following conditions were used: 95 °C for 3 min, then 95 °C for 5 s and 63 °C
for 30 s. The last two steps were repeated for 40 cycles with ﬂuorescence levels detected at the end of
each cycle. Speciﬁcity of the primers was ensured with gel electrophoresis and with melting curve
analysis. The transcripts were normalized to quantiﬁcation cycle (Cq) values for the tufA gene and the
comparative threshold cycle CT method (2⫺ΔΔCT) (60) was used to obtain relative transcript levels.
Protein expression, sample preparation, and immunoblot analysis. Strains containing the expression plasmids were grown in LB medium (for E. coli) or heart infusion broth (HIB) (for Y. pestis). When
indicated, different concentrations of IPTG (Sigma) were added. The cultures were centrifuged (1 min,
12,000 ⫻ g), and the bacteria were lysed by boiling in 2⫻ SDS loading buffer. C. trachomatis L2/Scc4infected HeLa cells were cultured in RPMI 1640-10 medium containing aTC to induce Scc4 expression.
Cells were harvested at 24 hpi and lysed in 10 mM Tris-HCl (pH 7.6) and 8 M urea buffer. To determine
August 2020 Volume 202 Issue 15 e00132-20
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the protein levels, a bicinchoninic acid (BCA) kit (Thermo Fisher) was used. The proteins were separated
on polyacrylamide gels, transferred onto polyvinylidene diﬂuoride (PVDF) membranes (Millipore), and
subjected to immunoblot analysis using proper primary antibodies. Goat anti-mouse or anti-rabbit
IgG–alkaline phosphatase (Invitrogen) was used as the secondary antibody. Blots were developed using
a horseradish peroxidase-conjugated secondary antibody and the SuperSignalP chemiluminescent detection kit (Pierce). Density of the signals on the immunoblot was determined using ImageJ.
Statistical analysis. Data are presented as mean plus or minus standard deviation (SD). Statistical
analyses were performed using Prism version 6.0 (GraphPad Software, Inc., San Diego, CA). Analysis of
variance (ANOVA) or a t test was used for testing the differences between the groups; P values ⬍0.05
were considered signiﬁcant.
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